Seysara is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Almirall, Llc. The primary component is Sarecycline Hydrochloride.
| Product ID | 16110-247_46501118-219b-42a7-ad24-65a4ad7f42db |
| NDC | 16110-247 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Seysara |
| Generic Name | Sarecycline Hydrochloride |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-01-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209521 |
| Labeler Name | Almirall, LLC |
| Substance Name | SARECYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Tetracycline-class Drug [EPC],P-Glycoprotein Inhibitors [MoA],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2019-01-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209521 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-01-04 |
| Ingredient | Strength |
|---|---|
| SARECYCLINE HYDROCHLORIDE | 150 mg/1 |
| SPL SET ID: | b200957c-3004-4988-be97-9fd619a83649 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16110-245 | Seysara | sarecycline hydrochloride |
| 16110-246 | Seysara | sarecycline hydrochloride |
| 16110-247 | Seysara | sarecycline hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SEYSARA 87573629 5728717 Live/Registered |
ALMIRALL, LLC 2017-08-17 |
![]() SEYSARA 87058418 5740134 Live/Registered |
ALMIRALL, LLC 2016-06-02 |